COMPARATIVE STUDY OF SINGLE-DOSE AND THREE-DAY THERAPY FOR LAPAROSCOPIC CHOLECYSTECTOMY

Phase 4

• Conditions: aparoscopic Cholecystectomy

• Registration Number: JPRN-UMIN000005142
• Lead Sponsor: Kyoto Prefectural University of Medicine Division of Digestive Surgery, Department of Surgery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-25
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

Patients have been treated with other antibiotics before the start of study drug administration Patients were treated with quinolone antibacterial agent within one week before the start of study drug administration Treatment with oral administration in patients with severe infection is not expected to effect Complications have serious underlying disease, patients have difficulty assessing the safety and efficacy of drug testing Patients with a history of allergy to quinolone antibacterials Patients with Severe cardiac dysfunction, liver dysfunction Patients with severe renal impairment Patients with a history of epilepsy or other seizure disorder Pregnant women and lactating women and the women are pregnant may Patients who are considered unsuitable for the doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of surgical site infection

Secondary Outcome Measures

Name	Time	Method
Blood and Bile concentrations of LVFX